Dr. Kendra Thomson is an Associate Professor in the Department of Applied Disability Studies and a Doctoral-level Board Certified Behaviour Analyst. She completed a post-doctoral fellowship at York University with Dr. Jonathan Weiss, the CIHR Chair in Autism Spectrum Disorders Treatment and Care Research. Dr. Thomson earned her Ph.D. in Applied Behaviour Analysis from the University of Manitoba in 2011, her MA in Lifespan Development (Psychology) from Brock University in 2007, and her honours undergraduate degree in Psychology from the University of Manitoba in 2005.
Kendra Thomson
Associate Professor
heconversation.com/institutions/brock-university-1340
From this contributor
Training caregivers can help keep autistic children safe
Behavioral skills training helps ensure that people with autism not only understand a new safety skill but are able to perform it accurately.
Training caregivers can help keep autistic children safe
Explore more from The Transmitter
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.